Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 675 
ORIGINAL ARTICLE
Year : 2013  |  Volume : 19  |  Issue : 4  |  Page : 182-186

Role of tumor necrosis factor-α -308 G/A promoter polymorphism in gastric cancer


1 Department of Cell Biology, Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Begumpet, Hyderabad, India
2 Department of Gastroenterology, Osmania General Hospital, Hyderabad, India
3 Department of Genetics, Osmania University, Hyderabad, India

Correspondence Address:
Ananthapur Venkateshwari
Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Begumpet, Hyderabad - 500 016
India
Login to access the Email id

Source of Support: Financial assistance provided in the form of Senior Research Fellowship to Amar Chand by Council of Scientific and Industrial Research (CSIR), New Delhi, is kindly acknowledged. Authors acknowledge Department of Biotechnology (DBT), New Delhi for providing the Laboratory facilities, Conflict of Interest: None


DOI: 10.4103/1319-3767.114513

Rights and Permissions

Background/Aim: Gastric cancer (GC) is the fourth most common cancer and the second most common cause of cancer death world-wide after lung cancer. It is a multifactorial disease with the involvement of both genetic and environmental risk factors. Genetic variation in genes encoding cytokines and their receptors, determine the intensity of the inflammatory response, which may contribute to individual differences in severity of outcome of the disease. Tumor necrosis factor alpha (TNF-α) is a potent pro-inflammatory cytokine and acid inhibitor. A bi allelic G to A polymorphism at -308 upstream from the transcription initiation site of the promoter is associated with elevated TNF levels. The present study is aimed at evaluating the role of TNF-α-308 (G → A) gene polymorphism and susceptibility to GC. Subjects and Methods: A case-control study was carried out in 114 GC patients and 229 healthy control subjects. TNF-α genotyping at position-308 (G → A) was carried out by amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) method followed by agarose gel electrophoresis. Results: The distribution of TNF-α genotypes at -308 (G → A) were GG 28.07%, GA 66.67% and AA 5.26% in GC patients and GG 33.19%, GA 55.89% and AA 10.92% in control subjects. The frequencies of alleles G and A were 0.614 and 0.386 in GC patients and 0.611 and 0.389 in control subjects respectively. Conclusion: The study showed no significant difference in the distribution of genotype and allelic frequencies between GC patients and control subject.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2410    
    Printed45    
    Emailed0    
    PDF Downloaded424    
    Comments [Add]    
    Cited by others 2    

Recommend this journal